United States · FDA National Drug Code directory
Lidocaine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-078_ead2d6e4-62f7-3b3c-e053-2a95a90a4ccd
- Product NDC
- 76420-078
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Lidocaine Hydrochloride
- Labeler
- Asclemed USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19750616
- Source listing expiry
- 20261231
Source-listed ingredients
- LIDOCAINE HYDROCHLORIDE — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 mL in 1 VIAL, SINGLE-DOSE (76420-078-05) · 76420-078-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →